🔎 Trials Near Me

Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Texas

Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Texas

8 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Texas.

Cities in Texas

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Site Number - 1622, Houston
  • Site Number - 1628, San Antonio
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07032662

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

  • GC2402 Study Site 115, Houston
  • GC2402 Study Site 106, Sherman
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07540221

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  • National Neuromuscular Research Institute, Austin
  • NeuroCarePlus, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07091630

A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Advanced Neurology Epilepsy and Sleep Center/ANESC Research, El Paso
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06752356

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  • NeuroCarePlus, Houston
  • National Neuromuscular Research Institute, Irving
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06920004

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  • Clinical Study Site, Dallas
  • Clinical Study Site, Denton
  • Cinical Study Site, Houston
  • and 3 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 28, 2026 · NCT06858579

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Austin Neuromuscular Center- Site Number : 8400040, Austin
  • Gadolin Research - Beaumont- Site Number : 8400047, Beaumont
  • Uthealth - The University Of Texas Health Sciences Center At Houston- Site Number : 8400050, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT06290141

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

  • Neurology Rare Disease Center, Denton
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.